Search details
1.
Chemoprophylaxis Vaccination: Phase I Study to Explore Stage-specific Immunity to Plasmodium falciparum in US Adults.
Clin Infect Dis
; 71(6): 1481-1490, 2020 09 12.
Article
in English
| MEDLINE | ID: mdl-31621832
2.
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery.
J Infect Dis
; 208(5): 818-29, 2013 Sep 01.
Article
in English
| MEDLINE | ID: mdl-23840043
3.
Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials.
AIDS Behav
; 17(2): 760-72, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23090677
4.
Recruitment of Caribbean female commercial sex workers at high risk of HIV infection.
Rev Panam Salud Publica
; 34(2): 92-8, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-24096973
5.
Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients.
JAMA
; 304(3): 275-83, 2010 Jul 21.
Article
in English
| MEDLINE | ID: mdl-20639561
6.
A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016.
Public Health Rep
; 134(1): 72-80, 2019.
Article
in English
| MEDLINE | ID: mdl-30517057
7.
Substance use patterns of HVTN phase I clinical trial participants: Enrollment, risk reduction counseling and retention.
Vaccine
; 36(9): 1235-1242, 2018 02 21.
Article
in English
| MEDLINE | ID: mdl-29395528
8.
Feasibility of Identifying a Female Sex Worker Cohort at High Risk of HIV Infection in the Caribbean for HIV Vaccine Efficacy Trials: Longitudinal Results of HVTN 907.
J Acquir Immune Defic Syndr
; 71(1): 70-7, 2016 Jan 01.
Article
in English
| MEDLINE | ID: mdl-26761272
9.
Selection of HIV vaccine candidates for concurrent testing in an efficacy trial.
Curr Opin Virol
; 17: 57-65, 2016 04.
Article
in English
| MEDLINE | ID: mdl-26827165
10.
Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.
PLoS One
; 10(9): e0137666, 2015.
Article
in English
| MEDLINE | ID: mdl-26368824
11.
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials.
PLoS One
; 10(9): e0136626, 2015.
Article
in English
| MEDLINE | ID: mdl-26332672
12.
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.
Lancet Infect Dis
; 14(5): 388-96, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24560541
13.
Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.
J Acquir Immune Defic Syndr
; 63(2): 239-44, 2013 Jun 01.
Article
in English
| MEDLINE | ID: mdl-23446497
14.
Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.
AIDS
; 27(11): 1763-70, 2013 Jul 17.
Article
in English
| MEDLINE | ID: mdl-23807272
15.
Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses.
Vaccine
; 31(1): 114-9, 2012 Dec 17.
Article
in English
| MEDLINE | ID: mdl-23142302
16.
Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults.
PLoS One
; 7(1): e29231, 2012.
Article
in English
| MEDLINE | ID: mdl-22242162
17.
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects.
Vaccine
; 29(10): 1948-58, 2011 Feb 24.
Article
in English
| MEDLINE | ID: mdl-21216311
18.
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.
Lancet Infect Dis
; 11(7): 507-15, 2011 Jul.
Article
in English
| MEDLINE | ID: mdl-21570355
19.
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.
Vaccine
; 27(2): 243-9, 2009 Jan 07.
Article
in English
| MEDLINE | ID: mdl-18996425
20.
The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials.
J Acquir Immune Defic Syndr
; 48(1): 82-9, 2008 May 01.
Article
in English
| MEDLINE | ID: mdl-18391750